Mixed messages for screening sclerosis patients

0 comments

Mixed messages for screening sclerosis patients

The current ad hoc approach to screening systemic sclerosis patients for pulmonary hypertension is compromising patient care and needs clarification, experts say.

Read more

Fears Govt to freeze MBS items

0 comments

Fears Govt to freeze MBS items

Budget rumours are suggesting cuts to MBS items with the introduction of a freeze on indexation.

Read more

GPs lack confidence in shoulder pain

0 comments

GPs lack confidence in shoulder pain

Australian GPs are not managing shoulder pain according to best practice, rheumatologists say.

Read more

Settlement over Vioxx under fire

0 comments

Settlement over Vioxx under fire

Drug company Merck has reached a $540,000 settlement with Australians who claim rofecoxib (Vioxx) gave them heart problems, but a judge is questioning if the deal is fair.

Read more

New outcome measure for OA trials

0 comments

New outcome measure for OA trials

Changes in bone trabecular integrity can predict OA progression over three years and may be a promising new outcome measure for trials, international research shows.

Read more

Latest News

Two drugs stronger than one in osteoporosis

Two drugs stronger than one in osteoporosis

0

Two commonly used osteoporosis drugs work better when combined, according to a study that could herald a new era for managing the disease, particularly in patients with a high-risk of fracture.

Anticoagulant conundrum for PAH sclerosis

Anticoagulant conundrum for PAH sclerosis

0

Australia is in a state of ‘clinical equipoise’ over whether to anticoagulate systemic sclerosis patients with pulmonary hypertension, experts say.

Weight loss double whammy in gout

Weight loss double whammy in gout

0

Dramatic weight loss can reduce gout flares by lowering urate and by suppressing inflammatory responses to MSU crystals, experts have found.

view more
to get Rheumatology Update delivered to your inbox

Browse our newsletter archive

Advertisement

Rheumatology Update on Twitter

­